Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 708.90 M

Biogen Inc. Depreciation And Amortization is USD 708.90 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 33.75% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 530.00 M, a 8.70% change year over year.
  • Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 487.60 M, a 0.76% change year over year.
  • Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 483.90 M, a 4.06% change year over year.
  • Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 465.00 M, a -31.56% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased